Werba Rubin Papier Wealth Management Sells 49 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Werba Rubin Papier Wealth Management decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.1% during the 4th quarter, Holdings Channel reports. The firm owned 492 shares of the medical equipment provider’s stock after selling 49 shares during the quarter. Werba Rubin Papier Wealth Management’s holdings in Intuitive Surgical were worth $257,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. M.E. Allison & CO. Inc. bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at about $449,000. Seilern Investment Management Ltd purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth approximately $82,517,000. Sycomore Asset Management raised its stake in shares of Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after purchasing an additional 4,079 shares during the last quarter. Exome Asset Management LLC raised its stake in shares of Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after purchasing an additional 1,069 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. raised its stake in shares of Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after purchasing an additional 525 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In related news, EVP Robert Desantis sold 376 shares of the stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,967,734. This trade represents a 6.39 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Jamie Samath sold 108 shares of the company’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,746,819.42. This represents a 1.22 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 6,348 shares of company stock valued at $3,587,582 in the last three months. 0.80% of the stock is currently owned by company insiders.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $601.17 on Wednesday. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The company has a market cap of $214.12 billion, a price-to-earnings ratio of 93.79, a price-to-earnings-growth ratio of 5.74 and a beta of 1.39. The stock’s 50-day moving average is $561.88 and its two-hundred day moving average is $522.27.

Analyst Ratings Changes

ISRG has been the subject of several analyst reports. Jefferies Financial Group increased their price objective on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Raymond James increased their price target on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. UBS Group increased their price target on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research report on Monday, January 27th. Stifel Nicolaus increased their price target on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. Finally, Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.